The Arrival of Economic Evidence in Managed Care Formulary Decisions-Reference-Cited by-同舟云学术

The Arrival of Economic Evidence in Managed Care Formulary Decisions

Published:2005-07 Issue:7 Volume:43 Page:II-27
ISSN:0025-7079
Container-title:Medical Care
language:en
Short-container-title:

Author:

Neumann Peter J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Public Health, Environmental and Occupational Health

Reference17 articles.

1. Economic messages in prescription drug advertisements in leading medical journals.;Neumann;Med Care,2002

2. FDA actions against misleading or unsubstantiated economic and quality-of-life claims: an analysis of warning letters and notices of violation.;Stewart;Value in Health,2002

3. Evidence-based and value-based formulary guidelines.;Neumann;Health Aff (Millwood),2004

4. US Regulation of Pharmaceutical Outcomes Research: Presented at the ISPOR 5th Annual Meeting, Crystal City, VA, 24 May 2000.;Burke;Value in Health,2001

5. The FDA's regulation of health economic information.;Neumann;Health Aff (Millwood),2000c

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cost of blood: did you pay too much or did you get a good deal?;Transfusion;2010-04

2. Willingness to Pay for Cancer Prevention;PharmacoEconomics;2009-06

3. Pharmacoeconomic Concepts in Antiplatelet Therapy: Understanding Cost-Effectiveness Analyses Using Clopidogrel as an Example;Journal of Cardiovascular Pharmacology and Therapeutics;2008-06

4. Implantación de la guía para la incorporación de nuevos fármacos (GINF) en los hospitales andaluces;Farmacia Hospitalaria;2007-01

5. The state of cost–effectiveness analysis in American managed care;Expert Review of Pharmacoeconomics & Outcomes Research;2006-04